company logo
Applications are now open across Europe!

We want to reimagine community health. If you have a solution that puts people at the center of creating healthier communities, apply by February 28th for a chance to win the Reimagining Community Health Challenge.  

Are you improving the health of your community with person-centric solutions? Apply to amplify the impact of your project!   

Ashoka and The Johnson & Johnson Foundation have joined forces with the common goal of surfacing pioneering practices and growing the field of Community Health innovation in Europe.  

This challenge is the first Europe-wide challenge to find and support Community Health innovators. We want to build a health system that values wellbeing and prevention as much as it values treatment, acknowledging the importance that Community Health deserves. By making people within communities healthier, the innovations we support will inevitably improve those communities in other ways, making them more livable, equitable, and cohesive.   

We’re looking for pioneers across Europe - system entrepreneurs who are improving health outcomes within their communities by delivering person-centered solutions. The goal is to identify these innovators, help them grow their impact and build a community that fosters an enabling environment, creating systemic change across Europe. 

If this sounds like you, apply now for a chance to win EUR 50,000, the opportunity to embark on a journey with the Johnson & Johnson Foundation, and join the leading community of innovators reimagining what Community Health can look like in Europe.

Applications will be open from now until February 28, 2022. If you are a member of the health community and are working with systems-changing entrepreneurs, then spread the word and help us amplify the impact of their projects!    

Focus Area

We are particularly interested in initiatives which do one or all of the following: 

  • Make novel health interventions – improving health outcomes for individuals either through innovative health practices or access to new or expanded services that support different facets of community health and are integrated with primary care;  

  • Improve health equity – designing solutions that combat health disparities and improve health outcomes for marginalized communities, through improving social and/or environmental determinants;  

  • Strengthen community governance and agency – laying the groundwork for new processes and structures between communities, health actors, and systems that will enable community decision-making and financing, as well as promoting co-creation and self-advocacy that leads to improved health outcomes for all. 


8 Winners will 

  • Receive a minimum prize award of €50,000 each.

  • Winners will also be invited to explore the opportunity of a long term partnership with the J&J Foundation.

  • Have the opportunity to be part of building the first-of-its-kind network of Community Health innovators in Europe. They will embark on a tailored learning journey with their peers to enhance their scaling strategy, advocacy work, and collective impact on their way to achieve a system change

  • Be offered workshops, peer exchange, support by pro bono experts and mentors, and system mapping provided by Ashoka and Johnson & Johnson’s partners.

  • Be announced at the online ceremony in June.

Semifinalists (up to 15) will: 

  • Receive further feedback from experts from Johnson & Johnson, Ashoka or their partners  

  • Be referred as semifinalists in the announcement communications   

  • Have access to online platform to connect with their peers and collect additional feedback 

All eligible participants will: 

  • Have the opportunity to receive peer feedback via the Challenge online platform, including the opportunity to view, review and connect with other applicants of the Reimagining Healthcare Challenge. 

  • Receive feedback from Ashoka to improve their entry 


  • Monday 28th February: Final entry deadline
  • 2nd March – 28th March: Screening & Community review  
  • 30th March: Semifinalists' announcement
  • 31st March – 21st April: Refinement phase - semifinalists can edit applications  
  • 6th May: Shortlisting
  • 7th May – 31st May: Judges' review and due diligence
  • 6th June Winners announced

Eligibility Criteria

To apply:  

  • You must have incorporated as a non-profit, for-profit, or hybrid organization. 

  • You must be an established organization with a proven track-record (we will not accept idea-stage applications). 

  • Entries will only be accepted in English (winners will be expected to engage in activities that require English proficiency). 

  • We are open to applications from Europe, the following countries are our priority: United Kingdom, Spain, France, Italy, Germany, Belgium, The Netherlands, Switzerland.


Additional terms:  

  • Only one application per organization will be accepted. 

  • Employees of Johnson & Johnson, advertising agencies, promotion agencies and other service providers for this Challenge, their immediate family members (spouse, parent, child, sibling, regardless of where they reside) are not eligible. 

  • Partners or initiatives that haven’t been supported previously by Johnson & Johnson Foundation will be prioritized. 

  • If the applicant is a government official or represents a government body, there will be additional Healthcare compliance review required. 

Evaluation Criteria

Community Focus – Is it a truly person-centric solution? We want to see buy-in from the community you serve, and how you are helping them take control of their own and each other’s health outcomes. 

Collaboration –How well is the initiative integrated with the existing health system? We want to see that health professionals and other key community stakeholders are integral to the design of your solution.   

Innovation – Is the initiative truly unique and responsive? We want to see a novel approach which comes from a clear affinity and understanding for the community(s) you serve and how your solution was designed to meet their needs.  

Impact – Are you able to prove that your initiative is making a difference? We want to see sophisticated impact measures, and how they are being used to inform decisions making.  

Sustainability – Do you have long-term plan for increasing impact and creating lasting change?  


In addition to our evaluation criteria described above, the group of winning teams will be selected to represent the diversity of applications received and the diversity of the field. Diversity will refer to: gender, accessibility, class, ethnicity, race and age. Diversity can be showcased in the target audience of a project, its partners or the team representing it.

Terms and Conditions

Review the full Terms and Conditions of the Reimagining Community Health Challenge for more information about children and youth participation, intellectual property, use of prize money and more. 

Data Protection 

Applicants' entries will be published on the Challenge platform and accessible by the public. You can identify the sections of the application form that will be displayed publicly by their label “Public”. Entry information may also be shared with third parties for evaluating and processing the applications.  The Challenge Partners will implement appropriate measures to ensure the Applicant’s Confidential Information is not actively revealed to any third-party that is not necessary to such related activities. For more information about how the Challenge Partners will use your data, please see the Terms and Conditions of the Reimagining Community Health Challenge. 

Timeline ( time)
  • Application Stage
    Started at 10 Jan 01:00
    Ends on 28 Feb 17:50
  • Screening and Community Review
    Starts on 02 Mar 01:00
    Ends on 28 Mar 17:50
  • Refinement phase 
    Starts on 31 Mar 01:00
    Ends on 21 Apr 17:50
  • Judges' Review
    Starts on 07 May 01:00
    Ends on 31 May 17:50
  • Winners Announcement
    Starts on 06 Jun 18:00
Open Timeline
Join the community!

This is a space to get support, connect with peers and access resources.